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Abstract
This paper examines the effects on specific
pathogen-free (SPF) chicks when avian
metapneumovirus (aMPV) and Newcastle dis-
ease virus (NDV) La Sota strain vaccines are
co-administered. Day-old SPF chicks were
divided into five groups. The first group was
inoculated with sterile water (SW) and the rest
of the groups were inoculated with live NDV
vaccine VG/GA by the oculo-oral route. At 21
days-old, the unvaccinated chicks were again
inoculated with SW. The four VG/GA-vaccinated
groups were further inoculated with (i) SW,
(ii) live aMPV vaccine, (iii) live NDV La Sota,
or (iv) combined live NDV La Sota and live
aMPV, respectively. Chicks were monitored for
post-vaccination reactions and oropharyngeal
swabs were collected for vaccines detection.
Blood samples were collected to detect aMPV
ELISA and NDV haemagglutination-inhibition
antibodies. Twenty-one days following the sec-
ond vaccination, six chicks from each group
were challenged with virulent NDV or aMPV
respectively. Chicks were monitored for clini-
cal signs and mortality and oropharyngeal
swabs collected for aMPV detection. Results
showed that, when challenged with a virulent
aMPV, both chicks previously vaccinated with
VG/GA and subsequently given aMPV vaccine
singly or in combination with La Sota were
equally protected against clinical signs. Chicks
that were vaccinated against NDV either once
with VG/GA or followed by La Sota (singly or in
combination with aMPV) were fully protected
when challenged with velogenic NDV. We con-
cluded that simultaneous administration of
live aMPV and NDV La Sota vaccines have no
adverse effects on protection conferred by
either live vaccine. 
Introduction
In the last two decades, avian metapneu-
movirus (aMPV) infection has become an
important component of respiratory disease in
chickens. It is associated with swollen head
syndrome which also causes drop in egg quali-
ty and production (Cook, 2000; Cook and
Cavanagh, 2002; Sugiyama et al., 2006;
Alexander and Jones, 2008; Cecchinato et al.,
2011). Newcastle disease (ND), which is
caused by paramyxovirus serotype 1 (APMV-1),
remains as one of the most economically
important poultry diseases worldwide
(Alexander and Jones, 2008). For control and
prevention of ND, live and inactivated vaccines
are available for more than half a century
(Alexander and Jones, 2008). In contrast, live
and inactivated vaccines for aMPV control and
prevention were only available in the last two
decades and restricted to certain countries
(Cook, 2000; Cook and Cavanagh, 2002;
Alexander and Jones, 2008). It was reported
that when live aMPV and ND virus (NDV) vac-
cines were given in combination in day-old
chicks, both singly and dually vaccinated
chicks were equally protected against aMPV
challenge (Ganapathy et al., 2005, 2007). In
addition, protection against virulent NDV was
not affected in single and dual vaccination. It
has also been demonstrated that live aMPV and
NDV can be safely administered to broiler
chicks with NDV maternal antibodies
(Ganapathy et al., 2006). Working with another
important respiratory pathogen, Cook et al.
(2001) found that when aMPV and infectious
bronchitis virus (IBV) vaccines were co-
administered, the latter virus inhibited the
replication of aMPV vaccine virus, resulting in
reduced humoral antibody response to aMPV
vaccine, though protection against aMPV or
IBV challenges were not affected. There have
not been reports on co-administration of aMPV
and NDV La Sota vaccines, where the latter
vaccine is widely used in ND endemic coun-
tries, mostly after priming with another lento-
genic ND vaccine. This paper reports on the
protection conferred by live aMPV or NDV La
Sota vaccines applied singly or dually in chicks
already primed with a live NDV VG/GA vaccine
at day-old. 
Materials and methodsChickens
Eighty white Leghorn day-old specific patho-
gen-free (SPF) chicks (Lohmann Animal
Health Gmbh & Co., Cuxhaven, Germany)
were randomly allocated into five groups of six-
teen birds each and were placed in separate
isolators in an experimental house. Food and
water were provided ad libitum.Viruses
Live NDV VG/GA (AVINEW®), NDV La Sota
(BIO LA SOTA) and aMPV subtype B
(NEMOVAC®) vaccines were provided by
Merial SAS (Lyon, France). On the other hand,
as for aMPV challenge, a virulent subtype B
aMPV (Ganapathy et al., 2007) was carried out
as previously described. This virus was propa-
gated and titrated in tracheal organ cultures
(TOCs) (Cook et al., 1976). For NDV challenge,
the velogenic APMV-1 chicken/Italy/3015/00
(intra cerebral pathogenicity index of 1.8) was
used. This virus was kindly provided by
OIE:FAO and National Reference Laboratory
for Newcastle Disease and Avian Influenza,
Legnaro, Italy. The virus was grown and titrat-
ed in SPF embryonated eggs.Vaccine preparation
One vial each of VG/GA, La Sota or aMPV
vaccines was thoroughly mixed with 100 mL of
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sterile water (SW). For dual-vaccination, aMPV
followed by NDV La Sota were both mixed in
100 mL of SW. Immediately after preparation,
SW and the vaccines were placed in a cold box
containing crushed ice. Each chick received 50
µL of SW or the appropriate vaccine ocularly
and 50 µL orally.Experimental design
Day-old chicks were randomly divided into
five groups as shown in Table 1. One group was
inoculated with 0.1 mL of SW and the other
groups were inoculated with VG/GA. At 21 days
of age, the group which received SW was inoc-
ulated with 0.1 mL of SW (Group: SW:SW). The
four VG/GA-inoculated groups were further
inoculated as follows: i) the first was sham-
inoculated with SW (Group: VG/GA:SW); ii) the
second group received aMPV (Group:
VG/GA:aMPV); iii) the third group received
NDV La Sota (Group: VG/GA:LASOTA); and iv)
the forth group (Group: VG/GA:aMPV+LASO-
TA) was inoculated with both aMPV and NDV
La Sota vaccines simultaneously. Dosages
received by each bird were in accordance with
the manufacturer’s recommendations (Table
1). Three weeks after the second vaccination,
six birds from each group were transferred
into separate isolators and challenged with vir-
ulent aMPV. Each bird received 0.1 mL of 4.0
log10 CD50 of a virulent aMPV subtype B chal-
lenge virus via the ocular route. At the same
time and in a similar manner, another six
birds from each group were transferred into
new isolators. These chicks were challenged by
intraocular inoculation of 0.2 mL of 5.0 log10
EID50 velogenic Italian NDV isolate. Four birds
per group remained unchallenged and were
used to determine aMPV and NDV post-vacci-
nation antibody titres and NDV vaccine shed-
ding.Clinical signs
All chicks were observed every day and after
aMPV challenge were examined daily for clini-
cal signs and the severity scored as described
before (Jones et al., 1992; Catelli et al., 2010).
Briefly, a score of 0 (=no signs), 1 (=clear
nasal exudates), 2 (=turbid nasal exudates), 3
(=frothy eyes and/or swollen infraorbital
sinuses in conjunction with nasal exudates).
Following NDV challenge, all chicks were
examined daily for clinical signs and mortality.
Those birds showing signs of illness such as
paralysis were humanely killed.Sampling 
For aMPV and NDV vaccine detection wet
and dry swabs were collected from the orophar-
ynx of chicks at 0, 2, 7, 14 and 21 days post-
VG/GA vaccination and 7, 14, 21 and 28 days
following the second vaccination, oropharyn-
geal (OP) swabs were collected from vaccinat-
ed-unchallenged chicks. After virulent aMPV
challenge, OP swabs were collected at 5 and 7
days for the detection by real time-polymerase
chain reaction (RT-PCR) and virus isolation
(VI) of aMPV. Wet swabs previously moistened
in TOC medium [Eagles serum-free MEM with
glutamine, streptomycin (50 µg:mL) and peni-
cillin (50 U:mL)] were used. The dry and wet
swabs were processed for RT-PCR and VI
respectively. Swabs from the challenged birds
were processed individually whilst the other
swabs were pooled. As for serology, blood was
collected at 0, 14 and 21 days post-NDV VG/GA
vaccination and at 7, 14, 21 and 28 days post-
second vaccination from vaccinated-unchal-
lenged chicks. Prior to termination of the
experiment at 7 days post-challenge (aMPV or
NDV), blood was collected from 6 chicks per
challenge group for detection of aMPV ELISA or
NDV haemagglutination-inhibition (HI) anti-
bodies. Detection of viruses
Oropharyngeal swabs were examined for
aMPV by isolation in TOC (Catelli et al., 1998;
Ganapathy et al., 2005) and for aMPV genome
by RT-PCR as previously described (Cavanagh
et al., 1999; Ganapathy et al., 2005). Newcastle
disease vaccine VI was attempted following
VG/GA and after the LaSota vaccinations from
OP swabs by inoculation of 9 to 11 days old
embrionated chicken eggs. Detection of vaccinal antibodies 
Newcastle disease antibodies were detected
by HI (Allan and Gough, 1974). For detection of
aMPV antibodies, a commercial ELISA kit
(BioChek B.V., Gouda, The Netherlands) was
used and the assay was carried out as recom-
mended by the manufacturers.Statistics
The antibody titres within the groups were
log-transformed and then examined by analy-
sis of variance (ANOVA) with MINITAB® for
WINDOWS® 14 (MINITAB Ltd., Coventry, UK).
A P value of <0.05 was considered statistically
significant. 
ResultsClinical signs 
No clinical signs were observed after the
first or the second vaccinations. After aMPV
challenge, no clinical signs were seen in the
groups that received aMPV vaccine either
alone (VG/GA:aMPV) or in combination with
NDV La Sota (VG/GA:aMPV+LASOTA). In con-
trast, nasal exudate and watery eyes were
observed in the groups not given aMPV vaccine
[the following mean daily scores resulted:
                                                                 Co-administered aMPV and NDV live vaccines
Table 1. Experimental design for protection against virulent avian metapneumovirus or
Newcastle disease virus challenge in specific pathogen-free chicks vaccinated singly or in
combination.
Vaccination Challenge (21 days post-vaccination)
Groups            Birds, n Vaccination age, days                          Birds, n                   Challenge virus
                                                         Day-old                  21                                                                           
SW:SW                 16                           SW                     SW                                6                                  aMPV
                                                                                                                              6                                    NDV
                                                                                                                              4                           Unchallenged
VG/GA:SW           16                  NDV VG/GA°             SW                                6                                  aMPV
                                                                                                                              6                                    NDV
                                                                                                                              4                           Unchallenged
VG/GA:aMPV       16                   NDV VG/GA           aMPV#                              6                                  aMPV
                                                                                                                              6                                    NDV
                                                                                                                              4                           Unchallenged
VG/GA:LASOTA  16                   NDV VG/GA     NDV La Sota§                       6                                  aMPV
                                                                                                                              6                                    NDV
                                                                                                                              4                           Unchallenged
VG/GA:aMPV+    16                   NDV VG/GA          aMPV+                             6                                  aMPV
LASOTA                                                                 NDV La Sota                        6                                    NDV
                                                                                                                              4                           Unchallenged
SW, sterile water; aMPV, avian metapneumovirus; NDV, Newcastle disease virus. °6.52 log10 EID50, #2.4 log10 CCID50, §7.54 log10 EID50.
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SW:SW (0.5, day 5 post challenge), VG/GA:SW
(0.83, day 5 post challenge; 0.5, day 6 post chal-
lenge); VG/GA: LASOTA (0.5, day 6 post chal-
lenge)]. Also, no clinical signs were seen in
any of the NDV-vaccinated groups. However,
within five days post-NDV challenge, five out of
six chicks in the NDV-unvaccinated control
group (SW:SW) died and one was humanely
killed. Detection of avian metapneu-movirus
Groups that did not receive aMPV vaccine
remained negative for this virus (Table 2). In
aMPV-vaccinated chickens, the combined
(VG/GA:aMPV+LASOTA) vaccinated group was
positive for aMPV by RT-PCR at 7, 14 and 21
days post-vaccination, but the group that
received aMPV vaccine (VG/GA:aMPV) alone
was positive at only 7 days post-vaccination.
aMPV was only isolated from both aMPV-vacci-
nated groups at day 7 post-vaccination.
Five days following challenge with a virulent
aMPV, four out of six birds in the aMPV-unvac-
cinated groups were aMPV positive by VI, but
all six were positive by RT-PCR (Table 2). In
contrast, there was no detection of aMPV in
the aMPV-vaccinated groups except 1 of 6 in
the single aMPV-vaccinated group (VG/GA
:aMPV) which was positive by RT-PCR only.
Seven days after challenge, OP samples from
all groups were negative for aMPV by VI and
RT-PCR except for the VG/GA:LASOTA group
where one of six birds was positive for aMPV
by both methods.Detection of Newcastle disease virus
Newcastle disease vaccine VI was attempted
following VG/GA and after the La Sota vaccina-
tions. No NDV vaccine virus was detected in the
control group (SW:SW). In the NDV-vaccinated
groups, vaccine was isolated at two and seven
days post-VG/GA vaccination (Table 3), but not at
all following the NDV La Sota vaccination. Serology
No aMPV antibodies were detected in
groups that did not receive either aMPV vac-
cine or the challenge virus. Following aMPV
vaccination, there were no significant differ-
ences in the levels of aMPV antibodies
between the groups given aMPV alone
(VG/GA:aMPV) and those given aMPV in com-
bination with La Sota vaccine
(VG/GA:aMPV+LASOTA), except at 7 days,
where the titre in the latter group was signifi-
cantly higher than the singly vaccinated group
(Figure 1). Following the challenge, levels of
aMPV antibodies in the challenged groups
increased significantly than those of the
unchallenged chickens (Table 4). No NDV HI
antibodies were detected in the NDV-unvacci-
nated (SW:SW) group. In all other groups, anti-
bodies were detected either in chicks that were
vaccinated only with NDV VG/GA or those fol-
lowed by NDV La Sota. However, between the
groups, there were no significant differences
in the HI titres (Figure 2). As regards velo-
genic NDV challenge, there were no signifi-
cant differences in the levels of antibody titres
between the vaccinated-challenged and corre-
sponding vaccinated-unchallenged groups,
except that the titres of the dually vaccinated-
challenge group (VG/GA:aMPV+LASOTA) were
significantly lower than the corresponding vac-
cinated-unchallenged group (Table 4).
Discussion
In our previous work (Ganapathy et al.,
2005, 2007), it was demonstrated that when
live aMPV and VG/GA vaccines were given
simultaneously to day-old SPF chicks, the effi-
cacy of the vaccines was not affected. In addi-
tion, local and humoral immune responses in
SPF (Cook et al., 2001; Ganapathy et al., 2005,
2007; Ganapathy and Jones, 2007; Tarpey et al.,
2007) and broiler chicks (Ganapathy et al.,
2006) have been reported before. Those
reports concentrated on single or dual vaccina-
tion of young chicks. In some Asian, African
and Latin American countries where ND is
endemic, the live aMPV vaccines are often
administered simultaneously with live La Sota
vaccines, which are normally given to boost the
protection against ND field challenge. This
study was undertaken to examine the potential
effect of live aMPV and La Sota vaccines in
such situations when simultaneously adminis-
tered to chicks already vaccinated with another
lentogenic NDV vaccine. Chicks that had
already been primed with VG/GA were used to
                                                                                                              Ganapathy et al.
Table 2. Detection of vaccine or challenge aMPV virus in the swabs by reverse transcrip-
tase-polymerase chain reaction or passage in tracheal organ cultures.
Groups                        Methods of               Days post-aMPV                  Days post-virulent 
                                      detection                    vaccination                          aMPV challenge§
                                                                           0            7       14        21     28°                                   5                      7
SW:SW                         RT-PCR                       -            -        -          -         -                                     6                      0
                                     VI#                                -            -        -          -         -                                     4                      0
VG/GA:SW                  RT-PCR                       -            -        -          -         -                                     6                      0
                                     VI                                -            -        -          -         -                                     4                      0
VG/GA:aMPV               RT-PCR                       -           +       -          -         -                                     1                      0
                                     VI                                -           +       -          -         -                                     0                      0
VG/GA:LASOTA          RT-PCR                       -            -        -          -         -                                     6                      1
                                     VI                                -            -        -          -         -                                     4                      1
VG/GA:aMPV+           RT-PCR                       -           +      +        +        -                                     0                      0
LASOTA                       VI                                -           +       -          -         -                                     0                      0
aMPV, avian metapneumovirus; SW, sterile water; RT-PCR, reverse transcriptase-polymerase chain reaction; VI, virus isolation. °From
unchallenged groups; #attempted by TOC; §by oropharyngeal swabs.
Table 3. Detection of Newcastle disease virus in the swabs by passage in embryonated
chicken eggs.
Groups                        Days post-NDV VG/GA vaccination                  Days post-NDV La Sota vaccination
                                     0             2                 7           14        21                 7 (28)°      14 (35)     21 (42)   28 (49)
SW:SW                        -             -                  -             -           -                         -                  -                 -               -
VG/GA:SW                 -            +                +            -           -                         -                  -                 -               -
VG/GA:aMPV              -            +                +            -           -                         -                  -                 -               -
VG/GA:LASOTA         -            +                +            -           -                         -                  -                 -               -
VG/GA:aMPV+
LASOTA                      -            +                +            -           -                         -                  -                 -               -
NDV, Newcastle disease virus; SW, sterile water; aMPV, avian metapneumovirus. °Numbers in parenthesis represent days of age;
detection was attempted from unchallenged birds.
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mimic the common field practices in ND
endemic countries. In some countries, a
milder live lentogenic vaccine (e.g. B1, VG/GA)
are used within first few days of hatching and
14-21 later flocks are re-vaccinated with a live
La Sota vaccine to boost the protection levels
against field ND challenge. 
Based on findings from this experiment,
chicks that were vaccinated either singly with
aMPV or dually with NDV La Sota vaccines
were protected against virulent aMPV chal-
lenge. In addition, no aMPV was isolated from
the aMPV-vaccinated groups even though one
of six chicks in the VG/GA:aMPV was positive
for aMPV by RT-PCR. However, the detection of
aMPV genome in the absence of viable virus
isolation has been reported before (Hess et al.,
2004; Ganapathy et al., 2007). Thus, it appears
that simultaneous application of live aMPV and
NDV La Sota vaccines in chicks already primed
with NDV VG/GA showed no adverse effects in
conferring protection against aMPV challenge.
In this experiment, it was demonstrated that
both chicks that received either NDV VG/GA
alone at day-old or followed by NDV La Sota at
21 days old were protected against a velogenic
Italian NDV. No clinical signs or mortality were
recorded in these groups but all the chicks in
the NDV-unvaccinated group became ill, died
or were humanely killed. Although no attempts
were made to detect the NDV challenge virus
in the vaccinated-challenged chicks, based on
protection conferred against clinical signs and
mortality, it appears that aMPV vaccine does
not interfere with the protection conferred by
the NDV La Sota vaccine. Previously, it has
been shown that chicks simultaneously vacci-
nated with aMPV and NDV VG/GA vaccines
gave full protection against velogenic NDV
Texas GB strain (Ganapathy et al., 2007). This
appears to be the first study to demonstrate
protection conferred against velogenic NDV
and field aMPV by simultaneous vaccination
whit aMPV and La Sota in chickens.
To evaluate the immune responses to live
aMPV and NDV vaccines, humoral antibodies
were monitored following the vaccination. The
antibody levels were similar to previous report
                                                                 Co-administered aMPV and NDV live vaccines
Table 4. Avian metapneumovirus and Newcastle disease virus post challenge mean anti-
body titres in groups of chicks vaccinated at day old with AVINEW and at 21 days old
vaccinated singly with NEMOVAC or NDV BIO LA SOTA or with a combination of both
vaccines.
Groups                                Antibody assay     Challenge virus
                                                                  aMPV NDV
                                                                             Unchallenged     Challenged°          Unchallenged   Challenged°
SW:SW                                NDV HI                              -                            -                               <2                  All died
                                            aMPV ELISA              213a (50)           1459b (335)                       -                          -
VG/GA:SW                          NDV HI                              -                            -                        4.67 (0.52)        5.67 (0.61)
                                            aMPV ELISA             142a (41)           2461b (792)                       -                          -
VG/GA:aMPV                      NDV HI                              -                            -                        4.83 (0.38)        5.17 (0.49)
                                            aMPV ELISA            2779a (566)        5899b (1219)                      -                          -
VG/GA:LASOTA                 NDV HI                              -                            -                        5.17 (0.38)        4.50 (0.42)
                                            aMPV ELISA               98a (29)            1496b (286)                       -                          -
VG/GA:aMPV+LASOTA   NDV HI                              -                            -                        5.83a (0.4)       4.67b (0.52)
                                            aMPV ELISA            2818a (610)        5940b (1780)                      -                          -
aMPV, avian metapneumovirus; NDV, Newcastle disease virus; SW, sterile water; HI, haemagglutination-inhibition. °Blood collected
seven days after aMPV or NDV challenge. Numbers in parentheses indicate standard deviations. a,bDifferent upper case superscripts
between unchallenged and challenged groups indicate that the values differ significantly (P<0.05).
Figure 1. Mean avian metapneumovirus ELISA antibody titres in
the unvaccinated and vaccinated-unchallenged groups. Different
superscripts between groups indicate that the values differ signif-
icantly (P<0.05).
Figure 2. Mean Newcastle disease virus haemagglutination-inhi-
bition antibody titres in the unvaccinated and vaccinated-unchal-
lenged groups. There was no significant difference in the levels of
antibodies between the groups.
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(Ganapathy et al., 2007) where there were no
significant differences between the aMPV
singly or dually vaccinated groups, except on 7
days post-vaccination. In contrast, Tarpey et al.
(2007) reported that following administration
of live aMPV, IBV H120 and NDV C2 vaccines,
the humoral antibody response to aMPV were
significantly lower than the singly vaccinated
aMPV group. These findings reaffirm previous
reports that the protection was due to the local
and cell mediated immunity, which provided
protection against clinical signs and for clear-
ance of the challenge virus (Cook et al., 1989;
Jones et al., 1992; Khehra and Jones, 1999;
Ganapathy et al., 2005; Liman and
Rautenschlein, 2007).
For NDV HI titres, there were no significant
differences in the levels of humoral antibodies
between the groups that received single VG/GA
and those that also received La Sota vaccine.
Furthermore, the La Sota vaccine may have
induced the production of local antibodies
and/or cell-mediated immunity rather than
solely boosting the humoral antibody respons-
es. However, at 49 days post-vaccination, the
levels of antibodies in the groups that received
NDV La Sota were higher than the other
groups, thought not significantly. Roy et al.
(1997) vaccinated chicks with live lentogenic
followed by mesogenic NDV vaccines and
found no significant increase in the humoral
antibody titres. It has been reported that for
protection against NDV, local immunity on the
mucosal surface of respiratory tract plays an
important role in protection (Takada and Kida,
1996). At the time of challenge, each of the
NDV-vaccinated groups had HI titres above log2
5, which means that such titres were sufficient
or above the protective titre. Levels of humoral
antibody titres have been associated with pro-
tection against NDV (Beard and Brugh, 1975;
Kapczynski and King, 2005; van Boven et al.,
2008).
Conclusions
In conclusion, using NDV VG/GA-primed SPF
chicks, it was demonstrated that subsequent
simultaneous vaccination with live NDV La
Sota and aMPV vaccines does not adversely
affect the protection of the chicks against viru-
lent NDV or aMPV challenges. 
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